Alerts will be sent to your verified email
Verify EmailPANACEABIO
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Panacea Biotec Limited is a prominent Indian biotechnology company specializing in vaccines. It is acknowledged by UN Health Agencies for its significant role in the Global Polio Eradication Initiative.
Panacea Biotec major competitors are Sequent Scientific, Gufic Biosciences, Guj. Themis Biosyn, Orchid Pharma, Zota Health Care, Unichem Lab, Indoco Remedies.
Market Cap of Panacea Biotec is ₹3,386 Crs.
While the median market cap of its peers are ₹3,608 Crs.
Panacea Biotec seems to be less financially stable compared to its competitors.
Altman Z score of Panacea Biotec is 4.74 and is ranked 6 out of its 8 competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Jun Dec | |||||||||||||||||
Investor Presentation | Mar Jun | Mar Dec | Jun | |||||||||||||||
Conference Call | ||||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|